Literature DB >> 9178752

Two separate mechanisms for ligand-independent activation of the estrogen receptor.

M K El-Tanani1, C D Green.   

Abstract

Transient transfection experiments in which three different estrogen response element-containing reporter genes were cotransfected into HeLa cells, together with constitutively expressed estrogen receptor (ER) constructs, demonstrate that activation of the transcription of the reporter genes by epidermal growth factor (EGF) and by cholera toxin with 3-isobutyl-1-methyl-xanthine, which elevate cellular cAMP, is dependent upon the presence of functional ER. Cotransfection of the reporter genes with truncated versions of the ER shows that the two non-ligand activators of ER require different regions of the receptor to produce their effects on transcription. EGF acts primarily by means of transactivation domain AF-1, whereas cAMP acts via transactivation domain AF-2 of the ER. A point mutation that removes a major site of inducible phosphorylation within the AF-1 domain of the ER abolishes the response to EGF, but the response to estradiol and cAMP is retained. Specific inhibition of cAMP-activated protein kinase (protein kinase A) prevents the response to elevated cAMP but does not affect EGF or estradiol responses. Overexpression of the protein kinase A catalytic subunit in HeLa cells results in an amplified response to estradiol, similar to that induced by cholera toxin with 3-isobutyl-1-methyl-xanthine. Comparable experiments performed using COS-1 cells produce similar results but also reveal cell type- and promoter-specific aspects of the activation mechanisms. Apparently, the ER may be activated by three different signal molecules, estradiol, EGF, and cAMP, each using a mechanism that is distinguishable from that of the others.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178752     DOI: 10.1210/mend.11.7.9939

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  30 in total

1.  Ligand-independent activation of oestrogen receptor alpha by caveolin-1.

Authors:  A Schlegel; C Wang; R G Pestell; M P Lisanti
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

Review 2.  Estrogen and progesterone receptors: from molecular structures to clinical targets.

Authors:  Stephan Ellmann; Heinrich Sticht; Falk Thiel; Matthias W Beckmann; Reiner Strick; Pamela L Strissel
Journal:  Cell Mol Life Sci       Date:  2009-03-31       Impact factor: 9.261

3.  Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.

Authors:  D Chen; P E Pace; R C Coombes; S Ali
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains.

Authors:  D M Tanenbaum; Y Wang; S P Williams; P B Sigler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 5.  Crosstalk between the insulin-like growth factors and estrogens in breast cancer.

Authors:  D Yee; A V Lee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

6.  Expression of estrogen receptor α and growth factors in human prolactinoma and its correlation with clinical features and gender.

Authors:  H Lv; C Li; S Gui; Y Zhang
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

7.  Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells.

Authors:  Wai-Sum Lau; Wen-Fang Chen; Robbie Yat-Kan Chan; De-An Guo; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2009-03-09       Impact factor: 8.739

8.  Effect of raloxifene and its interaction with human PTH on bone formation.

Authors:  Y Lin; L J F Liu; T Murray; J Sodek; L Rao
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 9.  Cellular targets of estrogen signaling in regeneration of inner ear sensory epithelia.

Authors:  Jennifer S McCullar; Elizabeth C Oesterle
Journal:  Hear Res       Date:  2009-02-06       Impact factor: 3.208

Review 10.  Modulation of PPAR activity via phosphorylation.

Authors:  Katherine A Burns; John P Vanden Heuvel
Journal:  Biochim Biophys Acta       Date:  2007-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.